151 related articles for article (PubMed ID: 30801855)
1. Bcl-2 is a prognostic marker and its silencing inhibits recurrence in ameloblastomas.
Kim JY; Kim J; Bazarsad S; Cha IH; Cho SW; Kim J
Oral Dis; 2019 May; 25(4):1158-1168. PubMed ID: 30801855
[TBL] [Abstract][Full Text] [Related]
2. Effect of technetium-99 conjugated with methylene diphosphonate (
Shen S; Wang W; Yang C; Xu B; Zeng L; Qian Y
J Oral Pathol Med; 2019 Feb; 48(2):129-135. PubMed ID: 30421571
[TBL] [Abstract][Full Text] [Related]
3. [Detection of the apoptosis-suppressing oncoprotein bcl-2 in ameloblastomas].
Gao Y; Yang L; Zhu X
Zhonghua Bing Li Xue Za Zhi; 1995 Apr; 24(2):78-9. PubMed ID: 7788731
[TBL] [Abstract][Full Text] [Related]
4. Expressions of bax, bcl-2 and Ki-67 in odontogenic keratocysts (Keratocystic Odontogenic Tumor) in comparison with ameloblastomas and radicular cysts.
Soluk Tekkeşın M; Mutlu S; Olgaç V
Turk Patoloji Derg; 2012; 28(1):49-55. PubMed ID: 22207432
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of bone remodeling molecules expression in different types of jaw ameloblastoma.
Iakovou M; Chrysomali E; Piperi E; Fanourakis G; Sklavounou A; Vlachodimitropoulos D; Tseleni-Balafouta S
J Oral Pathol Med; 2015 Aug; 44(7):543-51. PubMed ID: 25243582
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical demonstration of bcl-2 protein in ameloblastoma.
Mitsuyasu T; Harada H; Higuchi Y; Kimura K; Nakamura N; Katsuki T; Kubota E; Toyoshima K; Ohishi M
J Oral Pathol Med; 1997 Sep; 26(8):345-8. PubMed ID: 9379422
[TBL] [Abstract][Full Text] [Related]
7. Two relatively distinct patterns of ameloblastoma: an anti-apoptotic proliferating site in the outer layer (periphery) and a pro-apoptotic differentiating site in the inner layer (centre).
Sandra F; Nakamura N; Mitsuyasu T; Shiratsuchi Y; Ohishi M
Histopathology; 2001 Jul; 39(1):93-8. PubMed ID: 11454049
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin (OPG) binds with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): suppression of TRAIL-induced apoptosis in ameloblastomas.
Sandra F; Hendarmin L; Nakamura S
Oral Oncol; 2006 Apr; 42(4):415-20. PubMed ID: 16413220
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
10. Establishment of ameloblastoma cell line, AM-1.
Harada H; Mitsuyasu T; Nakamura N; Higuchi Y; Toyoshima K; Taniguchi A; Yasumoto S
J Oral Pathol Med; 1998 May; 27(5):207-12. PubMed ID: 9682983
[TBL] [Abstract][Full Text] [Related]
11. Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro.
Wang A; Zhang B; Huang H; Zhang L; Zeng D; Tao Q; Wang J; Pan C
BMC Cancer; 2008 Jun; 8():182. PubMed ID: 18588710
[TBL] [Abstract][Full Text] [Related]
12. A study of the distribution of B-cell lymphoma/leukemia-2 in odontogenic cyst and tumors: Histochemical study.
Phull K; Metgud R; Patel S
J Cancer Res Ther; 2017; 13(3):570-575. PubMed ID: 28862228
[TBL] [Abstract][Full Text] [Related]
13. DNA damage response activation and cell cycle dysregulation in infiltrative ameloblastomas: A proposed model for ameloblastoma tumor evolution.
Diniz MG; Guimarães BVA; Pereira NB; de Menezes GHF; Gomes CC; Gomez RS
Exp Mol Pathol; 2017 Jun; 102(3):391-395. PubMed ID: 28454892
[No Abstract] [Full Text] [Related]
14. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.
da Silva TA; Batista AC; Mendonça EF; Leles CR; Fukada S; Cunha FQ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):333-41. PubMed ID: 18061491
[TBL] [Abstract][Full Text] [Related]
15. Detection of apoptosis-related factors and apoptotic cells in ameloblastomas: analysis by immunohistochemistry and an in situ DNA nick end-labelling method.
Kumamoto H
J Oral Pathol Med; 1997 Oct; 26(9):419-25. PubMed ID: 9385580
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation pattern of apoptosis-related genes in ameloblastoma.
Costa S; Pereira NB; Pereira K; Campos K; de Castro WH; Diniz MG; Gomes CC; Gomez RS
Oral Dis; 2017 Sep; 23(6):779-783. PubMed ID: 28248452
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of bcl-2 family proteins in benign and malignant ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 1999 Sep; 28(8):343-9. PubMed ID: 10478958
[TBL] [Abstract][Full Text] [Related]
18. Anti-apoptotic role of the sonic hedgehog signaling pathway in the proliferation of ameloblastoma.
Kanda S; Mitsuyasu T; Nakao Y; Kawano S; Goto Y; Matsubara R; Nakamura S
Int J Oncol; 2013 Sep; 43(3):695-702. PubMed ID: 23835807
[TBL] [Abstract][Full Text] [Related]
19. Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2004 Jan; 33(1):46-52. PubMed ID: 14675140
[TBL] [Abstract][Full Text] [Related]
20. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
